您的位置: 首页 > 农业专利 > 详情页

A fixed molecule for cancer treatment
专利权人:
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
发明人:
KUENKELE, Klaus-Peter,FENN, Timothy,GARCIA-MARTINEZ, Juan, Manuel,HO, Jason,KOESSL, Christian,SEN, Saurabh,VOYNOV, Vladimir,WERNITZNIG, Andreas,ERYILMAZ, Ertan,GANESAN, Rajkumar,SHAABAN, Abdulsalam
申请号:
CL2019001684
公开号:
CL2019001684A1
申请日:
2019.06.19
申请国别(地区):
CL
年份:
2019
代理人:
摘要:
(a) All people can use it: all people can use it; all people can use it; all people can use it: the second Tianqi inducing adhesive collector (atir2) and cadrina 17 (cdh17) related to TNF (tril2) and cadrina (cdh17) and their medical use, efficacy synthesis and ampere; eacute; props containing these substances, m and ampere; 1. Use it as a therapeutic and / or prophylactic agent; oacute; n del C amp; Aacute; NCER. lt; / P gt;<;p>;LA PRESENTE INVENCIÓ;N SE REFIERE A MOLÉ;CULAS DE FIJACIÓ;N QUE SE FIJAN ESPECÍ;FICAMENTE AL RECEPTOR 2 DEL LIGANDO INDUCTOR DE LA APOPTOSIS RELACIONADO CON TNF (TRAILR2) Y A CADHERINA 17 (CDH17) Y SU USO MEDICINAL, COMPOSICIONES FARMACÉ;UTICAS QUE LAS COMPRENDEN Y MÉ;TODOS PARA USARLAS COMO AGENTES PARA EL TRATAMIENTO Y/O LA PREVENCIÓ;N DEL CÁ;NCER.<;/p>;
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充